At Manningham Medical Centre, you can find all the data about Medical Trial Tykerb. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Tykerb: Side effects, dosage, use with other drugs, and …

    https://www.medicalnewstoday.com/articles/tykerb
    Tykerb is a brand-name medication that contains the active drug lapatinib. This active drug is also available as a generic medication. A generic is an exact copy of …

FDA drug approval summary: lapatinib in combination …

    https://pubmed.ncbi.nlm.nih.gov/18849320/
    On March 13, 2007, the U.S. Food and Drug Administration approved lapatinib (Tykerb tablets; GlaxoSmithKline, Philadelphia), an oral, small molecule, dual tyrosine kinase …

Tykerb: Package Insert / Prescribing Information - Drugs.com

    https://www.drugs.com/pro/tykerb.html

    Tykerb Evaluation After Chemotherapy (TEACH): …

      https://clinicaltrials.gov/ct2/show/NCT00374322
      Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer. The safety and scientific validity of this study …

    Top 10 Tykerb Clinical Trials [2023 Studies] | Power

      https://www.withpower.com/clinical-trials/tykerb
      Tykerb is one of two drugs most frequently prescribed for the treatment of advanced breast cancer. Clinical trials for Tykerb are interested in discovering its …

    Clinical Development

      https://clinicaltrials.gov/ProvidedDocs/86/NCT02294786/SAP_001.pdf
      Clinical Development LAP016A/ Lapatinib/Tykerb Clinical Trial Protocol CLAP016A2410 / NCT02294786 A Randomised, Multicentre, Open Label, Phase II study of Prophylactic …

    Tykerb - Dual Tyrosine Kinase Inhibitor - Clinical Trials …

      https://www.clinicaltrialsarena.com/projects/lapatinib/
      Tykerb (lapatinib ditosylate) is an epidermal growth factor receptor (EGFR) and ErbB-2 (Her2/neu) dual tyrosine kinase inhibitor, under development by …

    Tykerb (lapatinib) | CenterWatch

      https://cms.centerwatch.com/directories/1067-fda-approved-drugs/listing/4340-tykerb-lapatinib
      Tykerb is supplied as a 250 mg tablet designed for oral administration. The recommended initial dose of the drug is 1,250 mg (five tablets) given orally once daily on days 1-21 …

    Top 10 Tykerb Clinical Trials [2023 Studies] | Power

      https://www.withpower.com/clinical-trials/tykerb/1
      Tykerb (Lapatinib) research studies recruiting patients need your help. Receive premium care & cutting edge treatments by enrolling in tykerb clinical trials today.

    TYKERB - Chemotherapy Drugs - Chemocare

      https://chemocare.com/chemotherapy/drug-info/TYKERB.aspx
      What TYKERB Is Used For: Treatment of patients with advanced or metastatic breast cancer that is HER-2 positive. Note: If a drug has been approved for one use, physicians …



    Need more information about Medical Trial Tykerb?

    At Manningham Medical Centre, we collected data on more than just Medical Trial Tykerb. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.